Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 18 Dec 2024

Effect of immune checkpoint inhibitor time-of-day infusion on survival in advanced biliary tract cancer: a propensity score-matched analysis

in Cancer Immunity and Immunotherapy

Yichen Zheng
Fanfan Shi
Lingqi Sun
Jiamin Guo
Tonghui Ren
Ji Ma

Frontiers in Immunology

doi 10.3389/fimmu.2024.1512972

882 views

Original Research

Published on 18 Dec 2024

Prognostic significance of hemoglobin, albumin, lymphocyte and platelet score in solid tumors: a pooled study

in Cancer Immunity and Immunotherapy

Jinze Li
Jing Zheng
Puze Wang
Dong Lv

Frontiers in Immunology

doi 10.3389/fimmu.2024.1483855

835 views

Case Report

Published on 18 Dec 2024

Toripalimab plus chemotherapy for metastatic muscle-invasive bladder cancer with a high tumor proportion score: a case report

in Cancer Immunity and Immunotherapy

Wei Ning
Pengkang Chang
Ji Zheng
Wei Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1485744

620 views

Original Research

Published on 18 Dec 2024

Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients

in Cancer Immunity and Immunotherapy

Alain Gelibter
Lucrezia Tuosto
Angela Asquino
Marco Siringo
Arianna Sabatini
Ilaria Grazia Zizzari
Angelica Pace
Fabio Scirocchi
Flavio Valentino
Serena Bianchini

Frontiers in Immunology

doi 10.3389/fimmu.2024.1483182

1,026 views

Original Research

Published on 17 Dec 2024

Activated hepatic stellate cell-derived small extracellular vesicles facilitate M2 macrophage polarization and hepatoma progression via miR-27a-3p

in Cancer Immunity and Immunotherapy

Yufeng Sun
Xiaoqian He
Jiayi Han
Wenxuan Yin
Haichen Wang
Jing Li
Weiqi Liu
Xingwang Kuai
Jiaying Lv
Juling Ji

Frontiers in Immunology

doi 10.3389/fimmu.2024.1489679

985 views

Review

Published on 17 Dec 2024

VISTA in hematological malignancies: a review of the literature

in Cancer Immunity and Immunotherapy

Yuanjia Duan
Xiaotong Ren
Xinyu Guo
Jiayi Xie
Zhaoyun Liu
Lijuan Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1466839

885 views

Original Research

Published on 17 Dec 2024

Identification and validation of the nicotine metabolism-related signature of bladder cancer by bioinformatics and machine learning

in Cancer Immunity and Immunotherapy

Yating Zhan
Min Weng
Yangyang Guo
Dingfeng Lv
Feng Zhao
Zejun Yan
Junhui Jiang
Yanyi Xiao
Lili Yao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1465638

1,397 views

Original Research

Published on 17 Dec 2024

Machine learning-based selection of immune cell markers in osteosarcoma: prognostic determination and validation of CLK1 in disease progression

in Cancer Immunity and Immunotherapy

Nan Zhang
Zhou Haizhen
Runqi Zhang
Xiaoju Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1468875

1,330 views

Original Research

Published on 17 Dec 2024

Ocular adverse events associated with antibody-drug conjugates: a comprehensive pharmacovigilance analysis

in Cancer Immunity and Immunotherapy

Heng Chen
Gefei He
Juanjuan Huang
Lin Hu
Junlong Ma

Frontiers in Immunology

doi 10.3389/fimmu.2024.1495137

1,846 views

Original Research

Published on 17 Dec 2024

Development of a recombinant human IgG1 monoclonal antibody against the TRBV5-1 segment of the T cell receptor for the treatment of mature T cell neoplasms

in Cancer Immunity and Immunotherapy

Michele Pitaro
Giovanni Antonini
Alessandro Arcovito
Francesco Buccisano
Alfredo De Lauro
Maria Irno Consalvo
Valentina Gallo
Noah Giacon
Giuseppe Felice Mangiatordi
Maddalena Pacelli

Frontiers in Immunology

doi 10.3389/fimmu.2024.1520103

754 views

Original Research

Published on 17 Dec 2024

Targeting liver cancer stem cells: the prognostic significance of MRPL17 in immunotherapy response

in Cancer Immunity and Immunotherapy

Jingjing Shao
Tianye Zhao
Jibin Liu
Peipei Kang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1519324

758 views

Original Research

Published on 17 Dec 2024

Leveraging single-cell and multi-omics approaches to identify MTOR-centered deubiquitination signatures in esophageal cancer therapy

in Cancer Immunity and Immunotherapy

Kang Tian
Ziang Yao
Da Pan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1490623

982 views

Brief Research Report

Published on 17 Dec 2024

Adjuvant immunotherapy after neoadjuvant immunochemotherapy and esophagectomy for esophageal squamous cell carcinoma: a real-world study

in Cancer Immunity and Immunotherapy

Jifeng Feng
Liang Wang
Xun Yang
Qixun Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1456193

899 views

Original Research

Published on 17 Dec 2024

The clinical value of local consolidative therapy for oligo-residual disease in PD-1/PD-L1 inhibitors-treated non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Yuqi Su
Pan Luo
Ling Ni
Jianbin Hu
Jie Weng
Erdong Shen
Qiang Zhou
Tao Chen
Jiwen Xiao
Jia Xiao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1525236

578 views

Original Research

Published on 17 Dec 2024

NRF-1 transcription factor regulates expression of an innate immunity checkpoint, CD47, during melanomagenesis

in Cancer Immunity and Immunotherapy

Kuldeep Makwana
Edwin J. Velazquez
Diego M. Marzese
Bethany Smith
Neil A. Bhowmick
Mark B. Faries
Omid Hamid
Alexander D. Boiko

Frontiers in Immunology

doi 10.3389/fimmu.2024.1495032

814 views

Original Research

Published on 17 Dec 2024

PAQR6 as a prognostic biomarker and potential therapeutic target in kidney renal clear cell carcinoma

in Cancer Immunity and Immunotherapy

Tao Zou
Zongming Jia
Jixiang Wu
Xuxu Liu
Minghao Deng
Xuefeng Zhang
Yuxin Lin
Jigen Ping

Frontiers in Immunology

doi 10.3389/fimmu.2024.1521629

771 views

Navigation group

Articles

Effect of immune checkpoint inhibitor time-of-day infusion on survival in advanced biliary tract cancer: a propensity score-matched analysis

Prognostic significance of hemoglobin, albumin, lymphocyte and platelet score in solid tumors: a pooled study

Toripalimab plus chemotherapy for metastatic muscle-invasive bladder cancer with a high tumor proportion score: a case report

Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients

Activated hepatic stellate cell-derived small extracellular vesicles facilitate M2 macrophage polarization and hepatoma progression via miR-27a-3p

VISTA in hematological malignancies: a review of the literature

Identification and validation of the nicotine metabolism-related signature of bladder cancer by bioinformatics and machine learning

Machine learning-based selection of immune cell markers in osteosarcoma: prognostic determination and validation of CLK1 in disease progression

Ocular adverse events associated with antibody-drug conjugates: a comprehensive pharmacovigilance analysis

Development of a recombinant human IgG1 monoclonal antibody against the TRBV5-1 segment of the T cell receptor for the treatment of mature T cell neoplasms

Targeting liver cancer stem cells: the prognostic significance of MRPL17 in immunotherapy response

Leveraging single-cell and multi-omics approaches to identify MTOR-centered deubiquitination signatures in esophageal cancer therapy

Adjuvant immunotherapy after neoadjuvant immunochemotherapy and esophagectomy for esophageal squamous cell carcinoma: a real-world study

The clinical value of local consolidative therapy for oligo-residual disease in PD-1/PD-L1 inhibitors-treated non-small cell lung cancer

NRF-1 transcription factor regulates expression of an innate immunity checkpoint, CD47, during melanomagenesis

PAQR6 as a prognostic biomarker and potential therapeutic target in kidney renal clear cell carcinoma